This article's central target is calculated from 25 individually verified analyst price targets, spanning roughly $1,015 to $1,400. The mean of approximately $1,232 was rounded to $1,230, implying about 17% upside from the recent close. This figure is an arithmetic average, not an official published consensus, and individual views vary sharply.
Bullish analysts cluster in the $1,200–$1,400 range. Recent examples include HSBC at $1,400, DBS at $1,320, J.P. Morgan at $1,300, and Bernstein and Evercore ISI each at $1,270. Mizuho upgraded the stock to Buy with a $1,275 target, and Raymond James moved to Strong Buy at $1,250. These analysts generally cite record bookings and a strengthening AI inference opportunity. I also checked this using Tickeron’s AI Daily Buy/Sell Signals to see how momentum aligns with the broader analyst picture.
More cautious voices sit well below the mean. EQIX rates the stock Neutral with a $1,015 target at Goldman Sachs, arguing near-term growth is "relatively modest" and that the shares lack a clear catalyst for multiple re-rating. Barclays holds an Equal-Weight rating at $1,130, and Scotiabank's Sector Perform stance carries a $1,120 target. This divergence—not any single analyst's number—explains the wide range.
EQIX closed at $1,053.79, within about 7% of its 52-week high of $1,128.68 and far above its 52-week low of $720.62. Reaching $1,230 requires a move of roughly 17%, a substantial but not extreme advance for a stock that gained about 40% year-to-date.
The path depends on whether the company can sustain revenue growth while defending its valuation. Third-quarter 2026 revenue rose about 11% year over year to roughly $2.59 billion, net income increased about 31%, and adjusted EBITDA grew about 15%. Management raised its 2026 revenue growth guidance to approximately 12%, supported by record bookings. However, revenue growth has decelerated from earlier quarters, a dynamic that weighs on sentiment even as profitability improves.
The 52-week high of $1,128.68 is the clearest resistance level, and a breakout above it would mark fresh all-time-high territory. The round $1,000 level and the 50- and 200-day moving averages near $1,019–$1,025 form a support zone that has held during recent pullbacks. Below that, the low-$900s served as a prior consolidation area. The stock's long-term uptrend remains intact, but the $1,130 area has repeatedly capped gains. From what I see, the technical structure supports the fundamental case but needs confirmation above resistance.
Analyst price targets typically reflect a roughly 12-month horizon, though individual assumptions vary. Key items to watch include the next earnings report, any further changes to 2026 guidance, AFFO trends, updates on bookings and pricing, interest-rate decisions that affect REIT valuations, and capital-spending plans. Analyst target revisions—especially from the more cautious firms near the bottom of the range—will signal whether the $1,230 level remains achievable. I’m watching this closely as new data comes in.
In my own workflow, Tickeron’s AI Daily Buy/Sell Signals provide an extra layer of insight by scanning thousands of stocks and ETFs in real time. The signals help flag shifts in technical behavior and market conditions that complement fundamental analysis, especially for a high-valuation name like EQIX. This automated perspective has become a regular part of how I monitor entry and exit points alongside earnings and guidance updates.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
EQIX moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend. In 30 of 43 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 70%.
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on EQIX as a result. In 51 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 58%.
The Moving Average Convergence Divergence (MACD) for EQIX just turned positive on October 28, 2026. Looking at past instances where EQIX's MACD turned positive, the stock continued to rise in 31 of 46 cases over the following month. The odds of a continued upward trend are 67%.
The 10-day moving average for EQIX crossed bullishly above the 50-day moving average on November 09, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 54%.
Following a +2.17% 3-day Advance, the price is estimated to grow further. Considering data from situations where EQIX advanced for three days, in 176 of 313 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EQIX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 54%.
EQIX broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for EQIX entered a downward trend on October 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Seasonality Score of 25 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 38 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 46 (best 1 - 100 worst), indicating steady price growth. EQIX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 58 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 67 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.948) is normal, around the industry mean (1.837). EQIX has a moderately high P/E Ratio (65.001) as compared to the industry average of (27.919). Projected Growth (PEG Ratio) (2.846) is also within normal values, averaging (2.612). Dividend Yield (0.020) settles around the average of (0.043) among similar stocks. EQIX's P/S Ratio (10.215) is slightly higher than the industry average of (5.594).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a real estate investment trust
Industry SpecialtyTelecommunications